Autologous CD5 CAR T-cells
/ Beijing GoBroad Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 05, 2024
CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia
(clinicaltrials.gov)
- P1/2 | N=54 | Recruiting | Sponsor: Beijing GoBroad Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • T Acute Lymphoblastic Leukemia
1 to 1
Of
1
Go to page
1